Member Login
|
Site Map
|
Disclaimer
|
Contact
|
Bookmark
Advanced Search
Text Size
|
Wednesday, May 14, 2008
Home
Site Map
About Neura.net
Editorial Board Biographies
Patricia K. Coyle, MD
Paul Fishman, MD, PhD
Corey C. Ford, MD, PhD
Edward J. Fox, MD, PhD
Stephen S. Kirzinger, MD
Hillel Panitch, MD
Anthony Traboulsee, MD
Neura
Parents, Pesticides, and Proteins: Pathogenetic Mechanisms of Parkinson’s Disease
Parents, Pesticides,and Proteins: Pathogenetic Mechanisms of Parkinson’s Disease
References
MS Clinical Trials: Updates and Debates
References
Clinical Trial Design
References
Highlights From the Literature
**Online Exclusive** Highlights
Advanced Imaging Techniques and MS Pathology
Hot Topic: Advanced Imaging Techniques and MS Pathology
References
Controversy: Melanoma and Neurodegenerative Disease
References
Resources: Medicine and the Web
References
Highlights from the Literature
Parasitism and Multiple Sclerosis Risk
Parasitism and Multiple Sclerosis Risk
References
Oral Therapies for Multiple Sclerosis
References
Falls in the Elderly
References
Highlights From the Literature
Experimental Autoimmune Encephalomyelitis and MS Drug Development
Of Mice and Men: Experimental Autoimmune Encephalomyelitis and MS Drug Development
References
Statins, Low Cholesterol, and Parkinson’s Disease
References
Molecular Biology of Huntington’s Disease
References
Highlights From the Literature
Issues in PPMS
Issues in Primary–Progressive Multiple Sclerosis
References
Vitamin D and Multiple Sclerosis
References
Parkinson’s Disease Therapy and Valvular Heart Disease
References
Fatigue in MS
References
Saving the Neuron-Part 3
Hot Topic: Saving the Neuron: Part 3
References
MS Therapies: A Look Ahead
References
Meeting Reports: Hot Topics From the Annual Meeting of the SFN
Highlights From the Literature
Archives
Saving the Neuron-Part 2
Hot Topic: Saving the Neuron: Part 2
References
Glial Cells: A Primer
References
Pediatric Multiple Sclerosis
References
Highlights From the Literature
Saving the Neuron-Part 1
Hot Topic: Saving the Neuron: Part 1
References
Management of Parkinson’s Disease: Current Approaches and Future Prospects
References
Perspectives on Long-Term Management of Multiple Sclerosis
**Online Exclusive** A Delicate Balance: Assessing the Newcomer
References
References
Highlights From the Literature
**Online Exclusive** Highlights
The Immune System and Its Role in MS-Part 3
Hot Topic: The Immune System and Its Role in MS: Part 3
Monoclonal Antibodies to Treat MS: Update on Natalizumab and TGN1412
**Online Exclusive** Summary Figure on Proposed Targets of Current MS Drugs
References
Huntington’s Disease: A Primer
References
Highlights From the Literature
**Online Exclusive** Highlights
The Immune System and Its Role in MS-Part 2
Hot Topic: The Immune System and Its Role in MS: Part 2
References
Statins and CNS Diseases
References
**Online Exclusive** Special Discussion: Statins and Their Use in CNS Diseases
Pregnancy in MS
References
**Online Exclusive** Pregnancy and MS: A Q&A With Dr. Patricia K. Coyle
Highlights From the Literature
The Immune System and Its Role in MS-Part 1
Hot Topic: The Immune System and Its Role in Multiple Sclerosis
References
Amyotrophic Lateral Sclerosis: A Primer
References
Treatments: Complementary and Alternative Medicine in the Treatment of Multiple Sclerosis
References
Highlights From the Literature
Neura Special Edition:
State of the Art Multiple Sclerosis Treatment
The Genetics of MS
References
Spotlight on Current RRMS Treatments
References
MS in Special Populations
References
Fall 2005
Toward Personalized Medicine for Neurodegenerative Disease
References
Differential Diagnosis of Parkinson’s Disease
References
Issues in Primary-Progressive Multiple Sclerosis
References
Highlights From the Literature
Spring 2005
The Genetics of Parkinson's Disease
References
Safety Profiles of the Immunomodulators in Multiple Sclerosis
Natalizumab Is Withdrawn From the Market and Clinical Trials
References
Multiple Sclerosis Variants and Masqueraders
References
Highlights From the Literature
Winter 2004
Emerging Neurological Infectious Diseases
References
Multiple Sclerosis: Potential New Drugs and Treatment Strategies
References
Perspectives From Practice: Patients and Clinical Trials
Quality of Life in Parkinson’s Disease
References
Highlights From the Literature
Fall 2004
Experimental Therapies for Alzheimer's Disease
References
Symptom Management in Multiple Sclerosis
References
Perspectives From Practice: MS Symptom Management
The Management of Levodopa-Induced Motor Fluctuations in Parkinson's Disease
Dopamine Agonists and Motor Fluctuations: Comment by Paul Fishman, MD, PhD
References
Highlights From the Literature
Summer 2004
Human Prion Diseases: A Primer
References
Vitamin D Supplementation in the Prevention of Multiple Sclerosis
References
Perspectives From Practice
References
Neuroprotective Strategies in the Treatment of Parkinson's Disease
Assessing Neuroprotection in Clinical Trials
References
Highlights From the Literature
Spring 2004
MRI Findings as a Predictor of CDMS
References
Perspectives From Practice
References
Postmarketing Surveillance of Drug Safety
References
Cannabis and Cannabinoids in Neurological Disease
References
Highlights From the Literature
Winter 2003
Managed Care Initiatives in AD
Costs of Other Chronic Neurological Diseases
References
References
Designing Office-Based Patient Education Programs
References
Infection and MS: The Controversy Continues
References
Highlights From the Literature
Fall 2003
MRI: Conventional and Experimental Applications
References
Focus on Magnetic Resonance Spectroscopy
References
Pregnancy and the Immune System in MS
References
NSAIDs in Alzheimer's Disease: The Controvery Continues
References
Highlights From the Literature
Summer 2003
MRI: Conventional and Experimental Applications
References
Focus on Magnetic Resonance Spectroscopy
References
Neurotrophic Growth Factors and Roles in Pathogenesis of Neurological Disease
References
Managed Care Perspective on Multiple Sclerosis
References
Highlights From the Literature
Spring 2003
Measuring Brain Atrophy in Alzheimer's Disease
Experimental Treatment of Alzheimer's Disease
References
Fatigue in Multiple Sclerosis: Common, Disabling, and Measurable
References
The Next Phase in Neurology: Neuroprotection
References
Differing Mechanisms of Actions of MS Therapies
Highlights From the Literature
Fall 2002
The Health Insurance Portability and Accountability Act (HIPAA): An Introduction
References
Treatment Adherence
Overcoming Injection Challenges
References
On the Horizon: Genetic Epidemiology
References
Highlights From the Literature
Spring 2002
Clinical Measurements of MS
Using Cognition as a Disease Marker: Pro and Con
References
Using MRI to Monitor CNS Diseases
References
Nurse Corner — Mental and Physical Fatigue: Considerations in MS
Selected Readings
References
Highlights From the Literature
Winter 2001
Multiple Sclerosis: An Overview
References
Making Strides: The Immunomodulator Story
References
Perspectives On Magnetic Resonance Imaging: An Interview With Corey C. Ford, MD, PhD
References
Highlights From the Literature
Neura.net Podcasts
Neura.net NeuraPod Frequently Asked Questions
Archives
Congress Coverage
AAN 2008
MS Trial Update 1: Investigational Therapies
Immunosuppressive Therapy
MS Patient Populations in Recent Clinical Trials
PD Trial Update
Diabetes and Dementia
Late-Breaking News in PD
MS Trial Update 2: Monoclonal Antibodies
B-Cell Depletion in MS
Gene Therapy’s Effects on Cognition in PD
Neutralizing Antibodies
Long-Term Imaging Studies
ALS and Italian Soccer Players
Late-Breaking News in MS and AD
ECTRIMS 2007
Pediatric Multiple Sclerosis
Imaging Studies
Switching Therapies
Neutralizing Antibodies
Oral Therapies
Monoclonal Antibodies
Direct Comparison Data REGARDing Relapses and Safety
Viruses Implicated in MS Development, Relapses
Updates on Disease-Modifying Therapies
Direct-Comparison Trials Confirm Efficacy, Safety of DMTs
Monoclonal Antibody Trial Results
Understanding Brain Atrophy in MS
Iron Oxide Particles Better MS Lesion Marker Than Gd
Mitoxantrone Induction Therapy Prolongs the Effect of IFN Maintenance Therapy
EDSS and MRI May Predict Cognitive Status
Potential for Neuronal Preservation and Repair Encouraging
AAN 2007
New Oral Drugs Show Promise in MS
Therapeutic Assessment in Alzheimer’s Disease
Mediterranean Diet and Mortality in Alzheimer’s
Mediterranean Diet and Mortality in Alzheimer’s
Effect of Statins on Beta Interferon MS Therapy
Illumination Through Magnetization
Advances in Parkinson’s Disease Therapy
Early Evolution of Multiple Sclerosis
The BECOME Study’s Comparison Findings
Multiple Sclerosis Therapy Update
Monoclonal Antibodies as MS Therapy
**ONLINE EXCLUSIVE** Monitoring Mitoxantrone Safety
**ONLINE EXCLUSIVE** Daclizumab in MS
**ONLINE EXCLUSIVE** Apathy Predicts Cognitive Impairment
Racial and Socioeconomic Disparities in Patients With Parkinsonism
Update on MS Clinical Trials
Defining a Clinically Meaningful Difference in PD
High Levels of Amyloid Deposition Seen in Lewy Body Dementia
Cytokine Levels: Potential Biomarkers for MS Clinical Response
Enhanced Benefit Observed With Combination Therapy
RENEWing Mitoxantrone's Safety Profile
Alemtuzumab: Results in Refractory MS and as Initial Treatment
MDS 2006:
Neura Special Report
DBS in PD: Issues for 2007
MAO Inhibitor Effective Across Populations
Rasagiline Not Associated With the “Cheese Effect”
Nonmotor Symptoms: A Cross-Sectional Analysis
Treatment of PD: Today and Tomorrow
Trial Acronym Key
Gene Transfer Therapy May Lead to Improvement in PD Motor Function
Developments in Dyskinesia Research: Trial Design
Adenosine A
2A
Receptor Antagonist Shows Mixed Results
PD and Melanoma Risk
Early Addition of Entacapone Improves “Wearing Off”
Redefining Neuroprotection in Research
Gambling and DA Use
ECTRIMS 2006
Friday, September 29, 2006
Tuesday, October 3, 2006
**ON-LINE EXCLUSIVE**: Long-term Data Continues to Support Safety and Quality of Life
New Pharmacologic Modalities in MS
Comparative Study of Immunomodulatory Agents
Understanding Adherence to Therapy and Triggers for Discontinuation
The MS Severity Scale: A New Classification Tool
Can Early Axonal Loss Be Slowed or Reversed?
Managing Spasticity and Bladder Dysfunction in MS
The Evolving Definition of Benign MS
Cost of Relapses in Relapsing–Remitting MS
EFNS 2006
Update on Parkinson’s Disease Treatment
Improving PD Therapy Adherence: Issues and Answers
Assessing Quality of Life in Neurodegenerative Disorders
Developments in Multiple Sclerosis Research
Movement Disorders: Assessing Behavioral and Psychiatric Complications
New Perspectives, New Strategies in the Treatment of Neurodegenerative Diseases
The Search for New Therapies in Inflammatory/Demyelinating CNS Disease
AAN 2006
Thursday, April 6, 2006
Monday, April 10, 2006
**ON-LINE EXCLUSIVE**: Behavioral Benefits in Alzheimer’s
Archives
International Congress of Parkinson's Disease and Movement Disorders 2006
Friday, November 3, 2006
Monday, November 6, 2006
World Parkinson Congress
Friday, February 24, 2006
Monday, February 27, 2006
Advances in Therapy of Parkinson's Disease
Quality of Life in Parkinson’s Patients
The Parkinson’s Disease–Melanoma Connection
Mechanisms of Neuroprotective Therapy
Treatment-Resistant Motor Aspects of PD
Nonmotor Components of PD
Basic Research: Toward Preventing PD
Six Parkinson's Disease Genes Identified So Far
EFNS 2005 & ANA 2005
Optimizing Parkinson’s Disease Treatment
Low LDL Cholesterol: Parkinson’s Disease Risk Factor?
Alzheimer’s Disease: Cognitive and Functional Findings
Predicting Conversion From MCI to Alzheimer’s Disease
Treatment Trends in Multiple Sclerosis
Transcranial Magnetic Stimulation May Be Helpful in Amyotrophic Lateral Sclerosis
ECTRIMS 2005 & ACTRIMS 2005
Friday, September 30, 2005
Monday, October 3, 2005
Experimental Agents in SPMS
Long-Term Follow-up Commentary
International Congress of Parkinson's Disease and Movement Disorders 2005
European Federation of Neurological Societies 2005
Monday, September 19, 2005
Tuesday, September 20, 2005
**ON-LINE EXCLUSIVE**: Benefits of Memantine Confirmed in Everyday Medical Practice
European Neurological Society 2005
E-Exclusive Coverage
European Federation of Neurological Societies 2004
Monday, September 6, 2004
Tuesday, September 7, 2004
American Academy of Neurology 2004
Tuesday, April 27, 2004
Wednesday, April 28, 2004
Thursday, April 29, 2004
ECTRIMS 2004
Monday, October 11, 2004
Tuesday, October 12, 2004
International Congress of Parkinson's Disease and Movement Disorders 2004
Tuesday, June 15, 2004
Wednesday, June 16, 2004
European Neurological Society 2004
Tuesday, June 29, 2004
Wednesday, June 30, 2004
ECTRIMS 2003
Thursday, September 18, 2003
Friday, September 19, 2003
European Neurological Society 2003
American Academy of Neurology 2003
Tuesday, April 1, 2003
Wednesday, April 2, 2003
Thursday, April 3, 2003
ACTRIMS/ECTRIMS 2002
European Neurological Society 2002
American Academy of Neurology 2002
PD Perspectives
Professional Digest
More Featured Articles
More Literature Reviews
Congress Coverage
More Congress Coverage
Podcasts
Archives
For Your Patients
Resources
Nurse Network
MS Scan
MS Scan: First Look
Stem Cell-Based Therapy in Multiple Sclerosis
Study Analysis Suggests PROMiSe in Men With Primary-Progressive Multiple Sclerosis
Higher Levels of Vitamin D Associated With Lower Risk of MS
Women, Men, MS, and Self-Efficacy
Economic Comparison of Immunomodulators
Potential Neuroprotection Seen With Testosterone Therapy in Men
Including Sexual Dysfunction in Neurologic Evaluations
Benefits With a Higher Dose
Ethnic Differences in Immune Response
Congress Coverage: American Academy of Neurology’s 59th Annual Meeting
How Satisfied Are MS-Certified Nurses With Their Jobs?
Roundup: Uncovering Genetic Factors Associated With Multiple Sclerosis
Improving Treatment Adherence in Patients With Chronic Disease
Hyperintense Lesions Shown To Indicate MS Disease Activity and Damage
Predicting MS Relapses: New Scoring Tool Combines Clinical and MRI Data
ECTRIMS Conference Coverage: Studies Conclude First-Line Treatments Are Equivalent in Efficacy
Caution Advised Before Initiating Anti-integrin Therapy in Multiple Sclerosis
A Case of MS, Depression, and Alcohol Abuse
Issue 17 (2008)
Cerebrospinal Fluid in MS Diagnosis
Clinical Measures Are Poor Predictors of Outcomes in Primary Progressive MS
Caution Advised Before Initiating Anti-integrin Therapy in MS
A Case of MS, Depression, and Alcohol Abuse
Issue 16 (2007)
How Satisfied Are MS-Certified Nurses With Their Jobs?
ECTRIMS Conference Coverage: Studies Conclude First-Line Treatments Are Equivalent in Efficacy
Predicting MS Relapses: New Scoring Tool Combines Clinical and MRI Data
Hyperintense Lesions Shown to Indicate MS Disease Activity and Damage
Issue 15 (2007)
Roundup: Uncovering Genetic Factors Associated With Multiple Sclerosis
Clinical Insights
Improving Treatment Adherence in Patients With Chronic Disease
Benefits With a Higher Dose
Ethnic Differences in Immune Response
Issue 14 (2007)
Potential Neuroprotection Seen With Testosterone Therapy in Men
Including Sexual Dysfunction in Neurologic Evaluations
Gender and Self-Efficacy
Clinical Insights: Self-Efficacy
Economic Comparison of Immunomodulators
Issue 13 (2007)
Higher Levels of Vitamin D Associated With Lower Risk of MS
Study Analysis Suggests PROMiSe in Men With PPMS
In the News: Stem Cell-Based Therapy in MS
In Memoriam: Linda Morgante, RN, MSN, MSCN
Issue 12 (2007)
Assessing the Needs of Patients and Caregivers Living With MS
Treating MS Symptoms and Side Effects of Immunomodulatory Therapy
New Strategies in MS Treatment
**ONLINE EXCLUSIVE** Patient Adherence to Therapy
Issue 11 (2006)
An Overview of Recent Clinical Findings
MS Developments in the News: Word of Mouth
Putting Research into Practice: Understanding the Relevance of Animal Data to Patients
An EAE Model Comparative Study
**ONLINE EXCLUSIVE** Pros and Cons of the EAE Model
**ONLINE EXCLUSIVE** Rethinking the Influence of Relapse on Disability
Issue 10 (2006)
Open and Mutual Communication Is Key to Patient Care
Language That Hurts
Novel Combination Immunomodulatory Approach to MS Therapy
Treatment Initiation: Is Earlier Better in MS?
Putting Research Into Practice: Shared Decision Making: Improving Care By Enhancing Communication
**ONLINE EXCLUSIVE** Antibodies to Epstein–Barr Virus May Forewarn of MS
**ONLINE EXCLUSIVE** Special Urologic Considerations in MS
Spring/Summer 2006
Mimics Complicate MS Diagnosis
Focus on an MS Masquerader: Neuromyelitis Optica
The Relationship Between Stress & MS Relapses
Disability Measures Predict Response to Interferon Treatment
Putting Research Into Practice: Imaging Metrics: Monitoring MS Progression and Therapeutic Response
Addressing Patients’ Imaging Concerns: An Interview With Patricia Kennedy
Winter 2006
No Significant Benefit to Bee Sting Therapy for the Treatment of MS
Pediatric MS Review: Can Children Be Treated Like Adults?
Low-Fat Diet Comparison in Patients With MS
Putting Research Into Practice: Managing Patient Expectations of Therapy
**ONLINE EXCLUSIVE** Updated McDonald Diagnostic Criteria Guidelines for 2005
Fall 2005
Cannabinoid Update
Study Shows
b
-Interferon Does Not Affect Pregnancy Outcomes, Although Discontinuation of Treatment Is Still Recommended
Discontinuation Rates of MS Immunomodulating Therapies: Insights Into Adherence?
Putting Research Into Practice: Medicare Part D: An Overview of Prescription Drug Coverage
**ONLINE EXCLUSIVE** Caregiver Experiences Differ in Men and Women: Study Shows Men Act as “Protectors,” Women as “Advocates”
**ONLINE EXCLUSIVE** Should Patients With MS Get the Flu Vaccine?
Summer 2005
**ONLINE EXCLUSIVE**: Exercise Programs Help Functional Performance but Not Quality of Life in MS
New Long-term Results Show That Early Immunomodulator Use Benefits Patients
Aging Issues, Stress Management, and Exercise Top List of Health Promotion Concerns of Women With Disabilities
Cigarette Smoking Increases MS Disease Progression as Well as Risk
Putting Research Into Practice: Combating MS-Related Disability
**ONLINE EXCLUSIVE**: Q&A, Talking About Disability With Cira Fraser, PhD, APRN, BC, MSCN
Spring 2005
**ONLINE EXCLUSIVE**: MS Risk: Lowest for November Newborns, Greatest for May Babies
Putting Research Into Practice: Combination-Regimen Trial Development Halts Natalizumab's Use
MS Certification Enhances Nurse Professionalism & Standardizes Care
Reducing MS-Related Fatigue: A Comparison
Drug-Response Indicator: MRI Scan Activity
Educational Attainment Is a Leading Employment Predictor for Adults With MS
December 2004
Caregiver Depression Is Related to Psychological and Physical Health Status in Patients With MS
Study Finds Baseline MSSE Score May Help Predict Adherence to Glatiramer Acetate Therapy
Targeting the Central Nervous System and Cervical Lymph Nodes Through Intranasal Administration of Interferon An Animal Model
Putting Research Into Practice: Identifying and Managing Depression
August 2004
Managing Skin Reactions Associated With MS Therapies
Are MS Patients Abusing Alcohol and Drugs?
Patients Express Feelings About Living With MS
Putting Research Into Practice: Avoiding Injection-Site Reactions
May 2004
A Closer Look at Complementary and Alternative Therapy Use
Study Suggests Cholesterol-Lowering Drug as Possible MS Therapy
Losing Mobility: Patient Perspectives
Driving With MS: Fatigue Is Not the Only Factor
Putting Research Into Practice: Helping Patients Manage Fatigue
January 2004
Reflexology for MS? Study Shows Benefit
Pain in MS Patients Is More Intense but Not More Frequent Than in General Population
A Closer Look at MS-Related Fatigue
Reducing Feelings of Abandonment Among Newly Diagnosed MS Patients
Editorial Board
Timely Topics in MS Nursing
New Insights Into MS Immunopathology: Implications for Treatments and Long-Term Outcomes
Conventional & Advanced MRI: Putting Imaging Capabilities Into Perspective
Patient Considerations in Disease Management
Timely Topics in MS Nursing
– TeleSessions
Disease-Modifying Therapies: Side Effect Management
Magnetic Resonance Imaging in MS
Disease-Modifying Therapies and Skin Care Management
TIMELY TOPICS TeleSessions
Multiple Sclerosis Reference Guide
Multiple Sclerosis Counseling Points
™
Monographs
Advanced Practice Nursing
Monograph & Key Slides
Best Practices
Nursing Monograph
Key Issues
Nursing Monograph
Case Management in Multiple Sclerosis: A Stage-by-Stage Guide to MS Care For Nurse Care Managers
Self-Study Materials
A Comprehensive Overview of MS Nursing
Nurses' Field Kit
Editorial Board
Making Strides
Special Edition: Your MS Questions and Answers
Frequently Asked MS Questions and Their Answers
Disease-Modifying Therapies (DMTs) for MS
Relationships, Intimacy, and Reproduction
Work and Disclosure of MS
Someone I Know Has MS
Resources
MS and the Web
MS and the Web
Special Tear-Out Page: In Search of Quality Information
Imaging Techniques and MS Research
**Online Exclusive** More Imaging Techniques
MS and Genetics
MS and Genetics
DNA, RNA, Genes: The Basics
Progress in Genetics Research
Managing Your Least Favorite Things: Have Medication,
Will Travel
Caregiving From a Distance
The History of MS
The History of MS
Managing Your Least Favorite Things: Heat-Related Pseudoattacks
Q & A: Getting the Most From Your Office Visits
MS Support Resources
Thinking of You, The Caregiving Partner: When A Child Has MS
Neuronal Repair and Protection in MS
Neuronal Protection and Repair in MS
Managing Your Least Favorite Things: Bladder and Bowel Problems
Bladder and Bowel Treatment Chart
Q & A: Your Questions Answered
Thinking of You, The Caregiving Partner: Rights in the Workplace
Staying on Track With Your MS Therapy
Staying on Track With Your MS Therapy
Research Data You Can Use: Reducing Injection-Site Reactions
Managing Your Least Favorite Things: The Cost of MS
Adding to the Cost of MS: Time Off From Work
**Online Exclusive** Private and Public Insurance
Q & A: Complementary & Alternative Medicines
Thinking of You, The Caregiving Partner: Marital Stress
Archives
MS in Special Populations
MS in Special Populations
Managing Your Least Favorite Things: Spasticity
Q&A: Your Questions Answered
Thinking of You, the Caregiving Partner: Intimacy
MS Drugs: An Overview of Potential Side Effects
MS Drugs: An Overview of Potential Side Effects
Update: The Touch™ Prescribing Program
Special Section: How to Read a Package Insert
Thinking of You, the Caregiving Partner: Getting Help for the Caregiver
MRI in Multiple Sclerosis
MRI in Multiple Sclerosis
Managing Your Least Favorite Things: Depression
Q&A: Your Questions Answered
Thinking of You, the Caregiving Partner: Dealing With Anger
Making Room for MS
Making Room for MS
Managing Your Least-Favorite Things: Medicare Part D Basics
Q&A: Clinical Trials
Thinking of You, the Caregiving Partner: Children & a Family Member With MS
Winter 2005
Understanding Progressive MS
Managing Your Least Favorite Things: Pain and Fatigue Revisited
Q & A: Your Questions Answered
Thinking of You: The Caregiving Partner—Mood Swings
Fall 2005
Making Sense of the Immune System in MS
Managing Your Least Favorite Things: Tremor and Speech Difficulties
Q & A: Men's Health
Thinking of You: The Caregiver Partner
Spring 2005
Your MS Primer
TYSABRI: Use Suspended
Managing Your Least Favorite Things: Injection-Site Reactions
Tips for Reducing Injection-Site Reactions
Q & A: Women's Health
Winter 2004
MS Treatment Update
Managing Your Least Favorite Things: Fatigue in MS
Q&A: Family and MS
Fall 2004
All About Relapses
Understanding Pseudoexacerbations
Managing Your Least Favorite Things: Pain
Q & A: Measuring MS
Summer 2004
Getting the Most from an Office Visit
Q & A: Neutralizing Antibodies
Managing Your Least Favorite Things: Bowel Problems
Spring 2004
Taking Control of Multiple Sclerosis
Managing Your Least Favorite Things: Sexual Dysfunction
Q & A: MRI
Winter 2003
Financial Planning in MS: Easing the Process
Q & A: Traveling
Managing Your Least Favorite Things: Gait Problems
Fall 2003
HIPAA: Knowing Your Medical Privacy Rights
What You Can Do to Safeguard Your Medical Information
How to File a Complaint
For More Information
Q & A: Self-injection
Managing Your Least Favorite Things: Bladder Problems
Bladder Problem Symptoms
Summer 2003
First-Person Perspective: Telling Your Family, Friends, and Employers About MS
How to Tell Your Family, Friends, and Employers About MS
References
Managing Your Least Favorite Things: Depression
References
Spring 2003
Multiple Sclerosis Treatment and Your Quality of Life
Are You Beginning Treatment for Multiple Sclerosis?
Managing Your Least Favorite Things: Spasticity
Resources
The West Wing
Fall 2002
MS Treatment Update
Sources
Least Favorite Things: Optic Neuritis
Sources
Q & A
Editorial Board
Gail Hartley, MSN, NP, MSCN
Patricia M. Kennedy, RN, CNP, MSCN
Mary Ann Picone, MD
For Your Patients
Making Strides
Perspectives for Patients
New MS Therapies Are Being Explored
How MS is Visualized in the Brain and Spinal Cord
Reducing the Risk of Falling
Comprehensive Web Site Selection for MS Patients
**Online Exclusive** Fatigue in MS
Improved MS Treatments Expected Soon
MS in Children
Managing MS Today
Medicare Part D: Important Things You Should Know
Top 10 Things to Know
Pregnancy and Multiple Sclerosis
Complementary and Alternative Medicine: Separating Fact From Fiction
What to Expect From Your Disease-Modifying Therapy
Should You Get a Flu Vaccine When You Have Multiple Sclerosis?
Multiple Sclerosis: Dispelling the Myths
References
How Safe Are Your Multiple Sclerosis Medications?
What is PML?
Participating in Clinical Trials
References
Stroke and TIA
References
Parkinson's Disease
References
How to Manage Migraine
References
Getting to Know Your MS: Relapses
If Your MS Symptoms Worsen: Questions That Your Doctor May Ask (and That You May Want to Ask Yourself)
References
How to Cope With MS-Related Fatigue
References
Therapy Adherence: Why It's Important
Challenges to Adherence
Things You Can Do to Help You Adhere to Your Therapy
Getting to Know Your Multiple Sclerosis: Symptoms
How to Avoid Bowel Problems
References
Building Safety and Evacuation Preparedness
Fire Safety at Home for People With Disabilities: A Checklist
Support Services for Patients With MS and Other CNS Diseases: Internet Resources
References
Multiple Sclerosis and Your Immune System
Multiple Sclerosis Treatment and Your Quality of Life
Are You Beginning Treatment for Multiple Sclerosis?
Preventing Falls in Parkinson's Disease
References
Glossary
Material Request
Case-Based Learning
A Case of Early Refractory Relapsing-Remitting Multiple Sclerosis
A Case of Vision Loss With Myelopathy
A Case of Abnormal Movement and Dementia
A Case of Aggressive Demyelinating Disease Refractory to Treatment
Continuing Education
Web Links
Care Facilities
Education
Government
Press
Publications
Publishers
References
Resources
Search Engines and Portals
Societies
Supported by an educational grant from Teva Neuroscience. This site is intended for U.S. audiences only.
This Web site is for use by healthcare professionals only. It is not meant to serve as a substitute for a consultation with your physician. If you are a patient and would like to see Neura.net's educational material for patients,
click here
. Some discussions of drugs and devices contained on this Web site may include mention of uses that have not been evaluated by the United States Food and Drug Administration for safety and efficacy. Please consult complete prescribing information for any of the drugs and devices discussed before using them.
© 2008 Neura.net. All rights reserved.
